The University of Queensland

A Phase 2A/2B placebo-controlled randomised clinical trial to test the ability of triheptanoin to protect primary airway epithelial cells obtained from patients with ataxia-telangiectasia against.... (2020–2023)

Grant type:

BrAshA-T Ataxia-Telangiectasia Research Funding

Researchers:

• 

  Dr Dave Coman

  ATH - Senior Lecturer
  

  Children's Health Queensland Clinical Unit

  Faculty of Medicine

Funded by:

BrAshA-T Ataxia-Telangiectasia Limited